Comparative ¹⁸F-FDG and ⁶⁸Ga-MY6349 PET/CT Imaging for Assessing TROP2 ADC Therapeutic Efficacy in EGFR-TKI Resistant Advanced NSCLC

Clinical trial NCT07685197 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07685197
Sponsor: Zhou Chengzhi
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC EGFR Activating Mutation EGFR-TKI-resistant Non-Small Cell Lung Cancer Trop2 PET/CT Imaging

Start date: 2026-07-01
Primary completion: 2028-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.